Liang‐I Kang

2.3k total citations · 2 hit papers
28 papers, 1.3k citations indexed

About

Liang‐I Kang is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Liang‐I Kang has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Liang‐I Kang's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Liang‐I Kang is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Liang‐I Kang collaborates with scholars based in United States, China and Taiwan. Liang‐I Kang's co-authors include Wendy M. Mars, George K. Michalopoulos, Broc T. McCune, Michael Diamond, Adam L. Bailey, Rita E. Chen, Annette Robichaud, James T. Earnest, Shamus P. Keeler and Natasha M. Kafai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

Liang‐I Kang

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

2020 528 citations Emma S. Winkler, Adam L. Bailey et al. Nature Immunology profile →
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer

2024 56 citations Jad I. Belle, John Baer et al. Cancer Discovery profile →

Peers

Countries citing papers authored by Liang‐I Kang

Since Specialization

Citations

This map shows the geographic impact of Liang‐I Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐I Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐I Kang more than expected).

Fields of papers citing papers by Liang‐I Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐I Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐I Kang. The network helps show where Liang‐I Kang may publish in the future.

Co-authorship network of co-authors of Liang‐I Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐I Kang. A scholar is included among the top collaborators of Liang‐I Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐I Kang. Liang‐I Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	deep-AMPpred: A Deep Learning Method for Identifying Antimicrobial Peptides and Their Functional Activities 2025 ·Journal of Chemical Information and Modeling ·Jun Zhao, (unknown), Liang‐I Kang, (unknown), (unknown), Yuan Rao, (unknown)	7
2	Biomimetic Nanodrug Prepared by Cell Exocytosis Induces Cancer Stem Cell Differentiation by Attenuating Wnt Signaling Pathway 2025 ·Advanced Healthcare Materials ·Juncai Zhang, (unknown), Jinchao Zhang, Liang‐I Kang, (unknown), (unknown), Jiao Meng, Xing‐Jie Liang, Dandan Liu	1
3	Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer breakdown → 2024 ·Cancer Discovery ·Jad I. Belle, (unknown), John Baer, Xiuting Liu, Varintra E. Lander, Jiayu Ye, (unknown), Brett L. Knolhoff, Faiz Ahmad, Liang‐I Kang, (unknown), Ryan C. Fields, Li Ding, Hyun Kim, Paolo P. Provenzano, Sheila A. Stewart, David G. DeNardo	56
4	Development of a deep learning algorithm for Paneth cell density quantification for inflammatory bowel disease 2024 ·EBioMedicine ·Liang‐I Kang, (unknown), Jon N. Marsh, Liang Lu, (unknown), (unknown), Talin Haritunians, (unknown), Emebet Mengesha, Dermot McGovern, Thaddeus S. Stappenbeck, S. Joshua Swamidass, Ta‐Chiang Liu	1
5	Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non–small cell lung cancer 2023 ·Science Translational Medicine ·Brett H. Herzog, John Baer, Nicholas Borcherding, Natalie L. Kingston, Jad I. Belle, Brett L. Knolhoff, Graham D. Hogg, Faiz Ahmad, Liang‐I Kang, (unknown), Chieh‐Yu Lin, Ramaswamy Govindan, David G. DeNardo	44
6	Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer 2023 ·Cancer Immunology Research ·(unknown), John Baer, (unknown), (unknown), Brett L. Knolhoff, Graham D. Hogg, Natalie L. Kingston, Liang‐I Kang, Varintra E. Lander, Jingqin Luo, (unknown), Mark A. Watson, Rebecca Aft, Ryan C. Fields, William G. Hawkins, David G. DeNardo	13
7	Movement of cerebrospinal fluid tracer into brain parenchyma and outflow to nasal mucosa is reduced at 24 h but not 2 weeks post-stroke in mice 2023 ·Fluids and Barriers of the CNS ·(unknown), Kirsten Coupland, (unknown), Liang‐I Kang, Frederick R. Walker, Neil J. Spratt	4
8	Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity 2023 ·Cancer Cell ·Xiuting Liu, Graham D. Hogg, Chong Zuo, Nicholas Borcherding, John Baer, Varintra E. Lander, Liang‐I Kang, Brett L. Knolhoff, Faiz Ahmad, Robin Osterhout, Anna Galkin, Jean‐Marie Bruey, Laura Carter, Cedric Mpoy, Kiran Vij, Ryan C. Fields, Julie K. Schwarz, Haeseong Park, Vineet Gupta, David G. DeNardo	53
9	Fibrosis induced by resident macrophages has divergent roles in pancreas inflammatory injury and PDAC 2023 ·Nature Immunology ·John Baer, Chong Zuo, Liang‐I Kang, (unknown), Nicholas Borcherding, Brett L. Knolhoff, (unknown), Yu Zhu, Liping Yang, (unknown), Mark A. Lewis, Nan Zhang, Ki-Wook Kim, Ryan C. Fields, Wayne M. Yokoyama, Jason C. Mills, Li Ding, Gwendalyn J. Randolph, David G. DeNardo	47
10	Disruption of thymic central tolerance by infection with murine roseolovirus induces autoimmune gastritis 2022 ·The Journal of Experimental Medicine ·Tarin M. Bigley, Liping Yang, Liang‐I Kang, José B. Sáenz, Francisco Victorino, Wayne M. Yokoyama	14
11	IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma 2022 ·Gastroenterology ·(unknown), Daoxiang Zhang, (unknown), Varintra E. Lander, Xiuting Liu, Liang‐I Kang, (unknown), Brett L. Knolhoff, Lin Li, Patrick Grierson, Marianna B. Ruzinova, David G. DeNardo, Kian‐Huat Lim	33
12	Stromal Reprogramming by FAK Inhibition Overcomes Radiation Resistance to Allow for Immune Priming and Response to Checkpoint Blockade 2022 ·Cancer Discovery ·Varintra E. Lander, Jad I. Belle, Natalie L. Kingston, John M. Herndon, Graham D. Hogg, Xiuting Liu, Liang‐I Kang, Brett L. Knolhoff, (unknown), John Baer, Chong Zuo, Nicholas Borcherding, (unknown), Cedric Mpoy, Jalen Scott, Michael C. Zahner, Buck E. Rogers, Julie K. Schwarz, Hyun Kim, David G. DeNardo	66
13	Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response 2022 ·Genome Medicine ·Anthony Z. Wang, Jay A. Bowman-Kirigin, Rupen Desai, Liang‐I Kang, (unknown), Bhuvic Patel, Saad M. Khan, (unknown), M. Caleb Marlin, Jingxian Liu, Joshua W. Osbun, Eric C. Leuthardt, Michael R. Chicoine, Ralph G. Dacey, Gregory J. Zipfel, Albert H. Kim, David G. DeNardo, Allegra A. Petti, Gavin P. Dunn	52
14	SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function breakdown → 2020 ·Nature Immunology ·Emma S. Winkler, Adam L. Bailey, Natasha M. Kafai, Sharmila Nair, Broc T. McCune, Jinsheng Yu, Julie M. Fox, Rita E. Chen, James T. Earnest, Shamus P. Keeler, Jon H. Ritter, Liang‐I Kang, (unknown), Annette Robichaud, Richard D. Head, Michael J. Holtzman, Michael Diamond	528
15	Tissue-type plasminogen activator suppresses activated stellate cells through low-density lipoprotein receptor-related protein 1 2015 ·Laboratory Investigation ·Liang‐I Kang, Kumiko Isse, Kelly Koral, William C. Bowen, Selen C. Muratoglu, Dudley K. Strickland, George K. Michalopoulos, Wendy M. Mars	8
16	Synthesis of IL-6 by Hepatocytes Is a Normal Response to Common Hepatic Stimuli 2014 ·PLoS ONE ·(unknown), Mu He, Liang‐I Kang, Michael Q. Ding, Josiah E. Radder, (unknown), Yu Hsuan Carol Yang, Shirish Paranjpe, William C. Bowen, Anne Orr, George K. Michalopoulos, Donna B. Stolz, Wendy M. Mars	101
17	Signals and Cells Involved in Regulating Liver Regeneration 2012 ·Cells ·Liang‐I Kang, Wendy M. Mars, George K. Michalopoulos	105
18	Hepatocyte proliferation and hepatomegaly induced by phenobarbital and 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene is suppressed in hepatocyte-targeted glypican 3 transgenic mice 2011 ·Hepatology ·Chih‐Wen Lin, Wendy M. Mars, Shirish Paranjpe, Shashikiran Donthamsetty, Vishakha Bhave, Liang‐I Kang, Anne Orr, William C. Bowen, Aaron Bell, George K. Michalopoulos	21
19	(-)-Epigallocatechin-3-Gallate (EGCG) increases osteogenic differentiation of human bone marrow stromal cells 2009 ·Bone ·(unknown), Liang‐I Kang, (unknown), Shih‐Ya Hung, Yaw‐Syan Fu, Hsuan‐Ti Huang	1
20	Estrogen Stimulates Female Biliary Epithelial Cell Interleukin-6 Expression in Mice and Humans 2009 ·Hepatology ·Kumiko Isse, Susan Specht, John G. Lunz, Liang‐I Kang, Yoshiaki Mizuguchi, Anthony J. Demetris	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact